47426-302-02 : NDC 2026 Code

47426-302-02 : Bupivacaine And Meloxicam ( Zynrelef )

Additionally :

You can get information about “47426-302-02” NDC code in 47426-302-02 in HTML format

HTML | 47426-302-02 in TXT (Plain Text) format

TXT | 47426-302-02 in PDF (Portable Document Format)

PDF | 47426-302-02 in XML format

XML formats.

NDC Code : 47426-302-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "47426-302-02",
    "PackageDescription": "1 CARTON in 1 KIT (47426-302-02)  / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-302-04)  / 10.5 mL in 1 VIAL, SINGLE-DOSE (47426-302-06) ",
    "NDC11Code": "47426-0302-02",
    "ProductNDC": "47426-302",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Zynrelef",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Bupivacaine And Meloxicam",
    "DosageFormName": "SOLUTION",
    "RouteName": "INFILTRATION",
    "StartMarketingDate": "20210701",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA211988",
    "LabelerName": "Heron Therapeutics, Inc.",
    "SubstanceName": "BUPIVACAINE; MELOXICAM",
    "StrengthNumber": "300; 9",
    "StrengthUnit": "mg/10.5mL; mg/10.5mL",
    "Pharm_Classes": "Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-07-08",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20210701",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}